-
2
-
-
0027430975
-
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection
-
Belshe RB, Clements ML, Dolin R, et al. Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. J Infect Dis 1993; 168:1387-95.
-
(1993)
J Infect Dis
, vol.168
, pp. 1387-1395
-
-
Belshe, R.B.1
Clements, M.L.2
Dolin, R.3
-
3
-
-
0028670689
-
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans
-
Keefer MC, Graham BS, Belshe RB, et al. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. AIDS Res Hum Retroviruses 1994; 10:1713-23.
-
(1994)
AIDS Res Hum Retroviruses
, vol.10
, pp. 1713-1723
-
-
Keefer, M.C.1
Graham, B.S.2
Belshe, R.B.3
-
4
-
-
0027178289
-
Induction of HIV-1 neutralizing and syncytium-inhibiting antibodies in uninfected recipients of HIV-1 IIIB rgp120 subunit vaccine
-
Schwartz DH, Gorse G, Clements ML, et al. Induction of HIV-1 neutralizing and syncytium-inhibiting antibodies in uninfected recipients of HIV-1 IIIB rgp120 subunit vaccine. Lancet 1993; 342:69-73.
-
(1993)
Lancet
, vol.342
, pp. 69-73
-
-
Schwartz, D.H.1
Gorse, G.2
Clements, M.L.3
-
5
-
-
0028024901
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1
-
Belshe RB, Graham BS, Keefer MC, et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. JAMA 1994; 272:475-80.
-
(1994)
JAMA
, vol.272
, pp. 475-480
-
-
Belshe, R.B.1
Graham, B.S.2
Keefer, M.C.3
-
6
-
-
0028167726
-
Immunization of HIV-infected patients with rgp160: Modulation of anti-rgp120 antibody spectrotype
-
Biselli R, Loomis LD, Bono VD, Burke DS, Redfield RR, Birx DL. Immunization of HIV-infected patients with rgp160: modulation of anti-rgp120 antibody spectrotype. J AIDS 1994; 7:1016-24.
-
(1994)
J AIDS
, vol.7
, pp. 1016-1024
-
-
Biselli, R.1
Loomis, L.D.2
Bono, V.D.3
Burke, D.S.4
Redfield, R.R.5
Birx, D.L.6
-
7
-
-
0029090494
-
Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160
-
Loomis LD, Deal CD, Kersey KS, Burke DS, Redfield RR, Birx DL. Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160. J AIDS 1995; 10:13-7.
-
(1995)
J AIDS
, vol.10
, pp. 13-17
-
-
Loomis, L.D.1
Deal, C.D.2
Kersey, K.S.3
Burke, D.S.4
Redfield, R.R.5
Birx, D.L.6
-
8
-
-
0028861377
-
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
-
Pantaleo G, Menzo S, Vaccarezza M, et. al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995; 332:209-16.
-
(1995)
N Engl J Med
, vol.332
, pp. 209-216
-
-
Pantaleo, G.1
Menzo, S.2
Vaccarezza, M.3
-
9
-
-
0029116868
-
High levels of anti-HIV-1 memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors
-
Rinaldo C, Huang X, Fan Z, et al. High levels of anti-HIV-1 memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J Virol 1995; 69:5838-42.
-
(1995)
J Virol
, vol.69
, pp. 5838-5842
-
-
Rinaldo, C.1
Huang, X.2
Fan, Z.3
-
10
-
-
0031033018
-
Vertical transmission of human immunodeficiency virus type 1: Seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein
-
Ugen KE, Srikantan V, Goedert JJ, Nelson RP Jr, Williams WV, Weiner DB. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein. J Infect Dis 1997; 175:63-9.
-
(1997)
J Infect Dis
, vol.175
, pp. 63-69
-
-
Ugen, K.E.1
Srikantan, V.2
Goedert, J.J.3
Nelson Jr., R.P.4
Williams, W.V.5
Weiner, D.B.6
-
11
-
-
0026681193
-
Vertical transmission of HIV infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type I
-
Ugen KE, Goedert JJ, Boyer J, et al. Vertical transmission of HIV infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type I. J Clin Invest 1992; 89:1923-30.
-
(1992)
J Clin Invest
, vol.89
, pp. 1923-1930
-
-
Ugen, K.E.1
Goedert, J.J.2
Boyer, J.3
-
12
-
-
0000402765
-
Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers
-
Rossi P, Moschese V, Broliden P, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci USA 1989; 86:8055-8.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 8055-8058
-
-
Rossi, P.1
Moschese, V.2
Broliden, P.3
-
13
-
-
0024408384
-
Mother-to-infant transmission of human immunodeficiency virus type 1: Association with prematurity or low anti-gp120
-
Goedert J, Mendez H, Drummond J, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet 1989; 2:1351-4.
-
(1989)
Lancet
, vol.2
, pp. 1351-1354
-
-
Goedert, J.1
Mendez, H.2
Drummond, J.3
-
14
-
-
0030665257
-
Vigorous HIV-1 specific CD4 T-cell responses associated with control of viremia
-
Rosenberg ES, Billings JM, Caliendo AM, et al. Vigorous HIV-1 specific CD4 T-cell responses associated with control of viremia. Science 1997: 278:1447-50.
-
(1997)
Science
, vol.278
, pp. 1447-1450
-
-
Rosenberg, E.S.1
Billings, J.M.2
Caliendo, A.M.3
|